Cargando…
Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect
Interindividual variation in a drug response among patients is known to cause serious problems in medicine. Genomic information has been proposed as the basis for “personalized” health care. The genome-wide association study (GWAS) is a powerful technique for examining single nucleotide polymorphism...
Autores principales: | Takahashi, Hiro, Sai, Kimie, Saito, Yoshiro, Kaniwa, Nahoko, Matsumura, Yasuhiro, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Okuda, Haruhiro, Ichinohe, Risa, Takahashi, Anna, Doi, Ayano, Odaka, Yoko, Okuyama, Misuzu, Saijo, Nagahiro, Sawada, Jun-ichi, Sakamoto, Hiromi, Yoshida, Teruhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134257/ https://www.ncbi.nlm.nih.gov/pubmed/25127363 http://dx.doi.org/10.1371/journal.pone.0105160 |
Ejemplares similares
-
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method
por: Takahashi, Hiro, et al.
Publicado: (2015) -
Analysis of Gene Expression Profiles of Soft Tissue Sarcoma Using a Combination of Knowledge-Based Filtering with Integration of Multiple Statistics
por: Takahashi, Anna, et al.
Publicado: (2014) -
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
por: Doi, Toshihiko, et al.
Publicado: (2015) -
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer
por: Doi, Toshihiko, et al.
Publicado: (2013) -
Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs
por: Ohtsu, Atsushi, et al.
Publicado: (1989)